Isolation of a native osteoblast matrix with a specific affinity for BMP2

Journal of Molecular Histology

Volumn 38, Issue 5, 2007, Pages 393-404

  Grünert, Martin ^a,b   Dombrowski, Christian ^a   Sadasivam, Murali ^a   Manton, Kerry ^a   Cool, Simon M ^a,c   Nurcombe, Victor ^a,c  

^a INSTITUTE OF MOLECULAR AND CELL BIOLOGY   (Singapore)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

BMP; Carbohydrate; Growth factor; Stem cell; Substrate

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; ENHANCED GREEN FLUORESCENT PROTEIN; HEPARIN BINDING PROTEIN; HYBRID PROTEIN;

ANIMAL CELL; ANION EXCHANGE CHROMATOGRAPHY; ARTICLE; BINDING AFFINITY; CELL FUNCTION; CELL GROWTH; CELL ISOLATION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; EXTRACELLULAR MATRIX; HISTOLOGY; HUMAN; HUMAN CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STEM CELL;

3T3 CELLS; ANALYSIS OF VARIANCE; ANIMALS; BINDING SITES; BONE MORPHOGENETIC PROTEINS; CELL LINE; CELLS, CULTURED; CHONDROITINASES AND CHONDROITIN LYASES; CHROMATOGRAPHY, ION EXCHANGE; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; GREEN FLUORESCENT PROTEINS; HEPARIN LYASE; HUMANS; MESENCHYMAL STEM CELLS; MICE; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; OSTEOBLASTS; PROTEIN BINDING; PROTEOGLYCANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 35848949580     PISSN: 15672379     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10735-007-9119-0     Document Type: Article

References (46)

1. Ai X, Do AT, Lozynska O, Kusche-Gullberg M, Lindahl U, Emerson CP Jr (2003) QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol 162:341-351
2. Armstrong L, Hughes O, Yung S, Hyslop L, Stewart R, Wappler I, Peters H, Walter T, Stojkovic P, Evans J et al (2006) The role of PI3K/AKT, MAPK/ERK and NFkappabeta signalling in the maintenance of human embryonic stem cell pluripotency and viability highlighted by transcriptional profiling and functional analysis. Hum Mol Genet 15:1894-1913
3. Brickman YG, Ford MD, Gallagher JT, Nurcombe V, Bartlett PF, Turnbull JE (1998) Structural modification of fibroblast growth factor-binding heparan sulfate at a determinative stage of neural development. J Biol Chem 273:4350-4359
4. Coombe DR, Kett WC (2005) Heparan sulfate-protein interactions: therapeutic potential through structure-function insights. Cell Mol Life Sci 62:410-424
5. Cowan CM, Aalami OO, Shi YY, Chou YF, Mari C, Thomas R, Quarto N, Nacamuli RP, Contag CH, Wu B, Longaker MT (2005) Bone morphogenetic protein 2 and retinoic acid accelerate in vivo bone formation, osteoclast recruitment, and bone turnover. Tissue Eng 11:645-658
6. Datta N, Holtorf HL, Sikavitsas VI, Jansen JA, Mikos AG (2005) Effect of bone extracellular matrix synthesized in vitro on the osteoblastic differentiation of marrow stromal cells. Biomaterials 26:971-977
7. Depprich R, Handschel J, Sebald W, Kubler NR, Wurzler KK (2005) Comparison of the osteogenic activity of bone morphogenetic protein (BMP) mutants. Mund Kiefer Gesichtschir 9:363-368
8. Esko JD, Lindahl U (2001) Molecular diversity of heparan sulfate. J Clin Invest 108:169-173
9. Fisher MC, Li Y, Seghatoleslami MR, Dealy CN, Kosher RA (2006) Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation. Matrix Biol 25:27-39
10. Fuchs E, Tumbar T, Guasch G (2004) Socializing with the neighbors: stem cells and their niche. Cell 116:769-778
11. Gallagher JT (1997) Structure-activity relationship of heparan sulphate. Biochem Soc Trans 25:1206-1209
12. Gama CI, Tully SE, Sotogaku N, Clark PM, Rawat M, Vaidehi N, Goddard WA III, Nishi A, Hsieh-Wilson LC (2006) Sulfation patterns of glycosaminoglycans encode molecular recognition and activity. Nat Chem Biol 2:467-473
13. Ghosh-Choudhury N, Abboud SL, Nishimura R, Celeste A, Mahimainathan L, Choudhury GG (2002) Requirement of BMP-2-induced phosphatidylinositol 3-kinase and Akt serine/threonine kinase in osteoblast differentiation and Smad-dependent BMP-2 gene transcription. J Biol Chem 277:33361-33368
14. Gospodarowicz D, Lepine J, Massoglia S, Wood I (1984) Comparison of the ability of basement membranes produced by corneal endothelial and mouse-derived Endodermal PF-HR-9 cells to support the proliferation and differentiation of bovine kidney tubule epithelial cells in vitro. J Cell Biol 99:947-961
15. Hallak LK, Kwilas SA, Peeples ME (2007) Interaction between respiratory syncytial virus and glycosaminoglycans, including heparan sulfate. Methods Mol Biol 379:15-34
16. Hollinger JO, Schmitt JM, Buck DC, Shannon R, Joh SP, Zegzula HD, Wozney J (1998) Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration. J Biomed Mater Res 43:356-364
17. Huang W, Carlsen B, Rudkin GH, Shah N, Chung C, Ishida K, Yamaguchi DT, Miller TA (2001) Effect of serial passage on gene expression in MC3T3-E1 preosteoblastic cells: a microarray study. Biochem Biophys Res Commun 281:1120-1126
18. Hwang NS, Varghese S, Puleo C, Zhang Z, Elisseeff J (2007) Morphogenetic signals from chondrocytes promote chondrogenic and osteogenic differentiation of mesenchymal stem cells. J Cell Physiol 212:281-284
19. Jackson RA, Murali S, van Wijnen AJ, Stein GS, Nurcombe V, Cool SM (2007) Heparan sulfate regulates the anabolic activity of MC3T3-E1 preosteoblast cells by induction of Runx2. J Cell Physiol 210:38-50
20. Jeon O, Song SJ, Kang SW, Putnam AJ, Kim BS (2007) Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. Biomaterials 28:2763-2771
21. Kreuger J, Spillmann D, Li JP, Lindahl U (2006) Interactions between heparan sulfate and proteins: the concept of specificity. J Cell Biol 174:323-327
22. Lian JB, Stein GS, Javed A, van Wijnen AJ, Stein JL, Montecino M, Hassan MQ, Gaur T, Lengner CJ, Young DW (2006) Networks and hubs for the transcriptional control of osteoblastogenesis. Rev Endocr Metab Disord 7:1-16
23. Long S, Truong L, Bennett K, Phillips A, Wong-Staal F, Ma H (2006) Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli. Protein Expr Purif 46:374-378
24. Manton KJ, Sadasivam M, Cool SM, Nurcombe V (2006) Bone-specific heparan sulfates induce osteoblast growth arrest and downregulation of retinoblastoma protein. J Cell Physiol 209:219-229
25. Marie P, Debiais F, Cohen-Solal M, de Vernejoul MC (2000) New factors controlling bone remodeling. Joint Bone Spine 67:150-156
26. Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD (2002) Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem 277:49175-49185
27. Murakami N, Saito N, Takahashi J, Ota H, Horiuchi H, Nawata M, Okada T, Nozaki K, Takaoka K (2003) Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. Biomaterials 24:2153-2159
28. Paine-Saunders S, Viviano BL, Economides AN, Saunders S (2002) Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J Biol Chem 277:2089-2096
29. Paredes R, Arriagada G, Cruzat F, Villagra A, Olate J, Zaidi K, van Wijnen A, Lian JB, Stein GS, Stein JL, Montecino M (2004) Bone-specific transcription factor Runx2 interacts with the 1alpha,25-dihydroxyvitamin D3 receptor to up-regulate rat osteocalcin gene expression in osteoblastic cells. Mol Cell Biol 24:8847-8861
30. Park K, Min BH, Han DK, Hasty K (2007) Quantitative analysis of temporal and spatial variations of chondrocyte behavior in engineered cartilage during long-term culture. Ann Biomed Eng 35:419-428
31. Proudfoot AE (2006) The biological relevance of chemokine-proteoglycan interactions. Biochem Soc Trans 34:422-426
32. Rauch F, Lauzier D, Croteau S, Travers R, Glorieux FH, Hamdy R (2000) Temporal and spatial expression of bone morphogenetic protein-2, -4, and -7 during distraction osteogenesis in rabbits. Bone 27:453-459
33. Ruppert R, Hoffmann E, Sebald W (1996) Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur J Biochem 237:295-302
34. Sidhu KS, Lie KH, Tuch BE (2006) Transgenic human fetal fibroblasts as feeder layer for human embryonic stem cell lineage selection. Stem Cells Dev 15:741-747
35. Stone B (2002) Dispatches from the last frontier of molecular and cell biology: biosynthesis of polysaccharides and proteoglycans of the cell surface and extracellular matrix. IUBMB Life 54:161-162
36. Sugahara K, Kitagawa H (2002) Heparin and heparan sulfate biosynthesis. IUBMB Life 54:163-175
37. Takada T, Katagiri T, Ifuku M, Morimura N, Kobayashi M, Hasegawa K, Ogamo A, Kamijo R (2003) Sulfated polysaccharides enhance the biological activities of bone morphogenetic proteins. J Biol Chem 278:43229-43235
38. Takahashi Y, Yamamoto M, Tabata Y (2005) Enhanced osteoinduction by controlled release of bone morphogenetic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. Biomaterials 26:4856-4865
39. Tumova S, Woods A, Couchman JR (2000) Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int J Biochem Cell Biol 32:269-288
40. Turnbull J, Powell A, Guimond S (2001) Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol 11:75-82
41. Urist MR (1965) Bone: formation by autoinduction. Science 150:893-899
42. Vandermoere F, El Yazidi-Belkoura I, Slomianny C, Demont Y, Bidaux G, Adriaenssens E, Lemoine J, Hondermarck H (2006) The valosin-containing protein (VCP) is a target of Akt signaling required for cell survival. J Biol Chem 281:14307-14313
43. Vandermoere F, El Yazidi-Belkoura I, Demont Y, Slomianny C, Antol J, Lemoine J, Hondermarck H (2007) Proteomics exploration reveals that actin is a signaling target of the kinase Akt. Mol Cell Proteomics 6:114-124
44. Vogelin E, Jones NF, Huang JI, Brekke JH, Lieberman JR (2005) Healing of a critical-sized defect in the rat femur with use of a vascularized periosteal flap, a biodegradable matrix, and bone morphogenetic protein. J Bone Joint Surg Am 87:1323-1331
45. Wurzler KK, Emmert J, Eichelsbacher F, Kubler NR, Sebald W, Reuther JF (2004) [Evaluation of the osteoinductive potential of genetically modified BMP-2 variants]. Mund Kiefer Gesichtschir 8:83-92
46. Zhao B, Katagiri T, Toyoda H, Takada T, Yanai T, Fukuda T, Chung UI, Koike T, Takaoka K, Kamijo R (2006) Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2. J Biol Chem 281:23246-23253